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Abstract
In many organisms early development is under control of the maternal genome and zygotic gene expression is delayed
until the mid-blastula transition (MBT). As zygotic transcription initiates, cell cycle checkpoints become activated and the
tempo of cell division slows. The mechanisms that activate zygotic transcription at the MBT are incompletely understood,
but they are of interest because they may resemble mechanisms that cause stem cells to stop dividing and terminally
differentiate. The unstable regulatory protein Geminin is thought to coordinate cell division with cell differentiation.
Geminin is a bi-functional protein. It prevents a second round of DNA replication during S and G2 phase by binding and
inhibiting the essential replication factor Cdt1. Geminin also binds and inhibits a number of transcription factors and
chromatin remodeling proteins and is thought to keep dividing cells in an undifferentiated state. We previously found that
the cells of Geminin-deficient Xenopus embryos arrest in G2 phase just after the MBT then disintegrate at the onset of
gastrulation. Here we report that they also fail to express most zygotic genes. The gene expression defect is cell-
autonomous and is reproduced by over-expressing Cdt1 or by incubating the embryos in hydroxyurea. Geminin deficient
and hydroxyurea-treated blastomeres accumulate DNA damage in the form of double stranded breaks. Bypassing the Chk1
pathway overcomes the cell cycle arrest caused by Geminin depletion but does not restore zygotic gene expression. In fact,
bypassing the Chk1 pathway by itself induces double stranded breaks and abolishes zygotic transcription. We did not find
evidence that Geminin has a replication-independent effect on transcription. We conclude that Geminin is required to
maintain genome integrity during the rapid cleavage divisions, and that DNA damage disrupts zygotic gene transcription at
the MBT, probably through activation of DNA damage checkpoint pathways.
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Introduction
In many metazoans embryonic development begins with a series
of extremely rapid cleavage divisions that quickly produce a
blastula containing thousands of cells. During this period
development is under the control of maternal RNAs stored in
the egg. Zygotic transcription is deferred until the mid-blastula
stage, at a point called the mid-blastula transition (MBT) in
Xenopus or the maternal-zygotic transition (MZT) in Drosophila
[1]. Concomitant with activation of the zygotic genome, the cell
cycle slows as gap phases are introduced between S and M phases.
This pattern of development is thought to be an adaptation that
rapidly provides enough cells to form a feeding larva, an important
consideration for organisms with eggs that develop outside the
mother’s body. Rapid cell cycles have also been observed in
mammalian embryos before gastrulation, suggesting that this
mechanism of generating a large number of undifferentiated cells
may be more widespread [2]. The mechanisms that switch on
zygotic transcription at the MBT are incompletely understood.
They may resemble those that induce the progeny of stem cells to
withdraw from the cell cycle and execute a program of terminal
differentiation.
The MBT occurs after a fixed number of cleavage divisions,
after the 12
th cleavage in Xenopus and after the 14
th in Drosophila
[3,4]. In both organisms, the time of the MBT can be advanced or
delayed by artificially increasing or decreasing ratio of nuclear
DNA to cytoplasm [5,6,7]. These observations led to the model
that the expanding mass of nuclear DNA titrates a cytoplasmic
transcriptional repressor during the cleavage divisions, and that
zygotic gene expression initiates when this factor is depleted. This
putative cytoplasmic repressor has never been identified, but
candidates include DNA N-methyl transferase 1 (Dnmt1) and the
Drosophila protein Tramtrack [1].
A second model proposes that zygotic gene expression is
controlled by a cell cycle-independent maternal ‘‘clock’’ that is
activated at the time of fertilization. Recent microarray studies in
Drosophila indicate that the transcription of most zygotic genes is
not influenced by the nuclear/cytoplasmic ratio and depends only
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also controls the destruction of maternal RNAs, which occurs in
parallel with zygotic gene activation. The RNA binding protein
Smaug may be one component of this clock. In Drosophila, Smaug is
required both for the initiation of zygotic transcription and for the
changes in the cell cycle that occur at the MBT [9,10]. Smaug
triggers the destruction of specific mRNAs by recruiting them to
the CCR4/POP2/NOT deadenylase complex [11]. Smaug may
affect the timing of the cell cycle by targeting RNAs encoding
Cdc25 and the mitotic cyclins. Cdc25 is the phosphatase that
triggers mitotic entry by removing two inhibitory phosphate
groups from the mitotic kinase Cdc2. In Drosophila, destruction of
Cdc25 at the MBT delays mitotic entry and causes the cell cycle
slowing [12].
A third model proposes that rapid cell cycling by itself inhibits
zygotic transcription. According to this model, ongoing DNA
replication or entry into mitosis aborts nascent zygotic transcripts.
In both Xenopus and Drosophila, zygotic gene activation occurs
precociously when cell cycling is inhibited with cycloheximide
[13,14]. Mitotic entry has also been directly shown to abort the
transcription of a long messenger RNA [15].
Cell cycle checkpoint mechanisms can also affect zygotic
transcription. Drosophila embryos that carry a mutation in
Chk1, the effector kinase of the DNA replication checkpoint
pathway, fail to slow the cell cycle and fail to express zygotic genes
at the MBT [16,17]. The Chk1 pathway delays entry into mitosis
until DNA replication is complete. Initially these results were
interpreted to mean that checkpoint-induced slowing of the cell
cycle is necessary for transcription. It was found, however, that
Chk1(2/2) embryos accumulate DNA damage in the form of
double stranded breaks [18], and that zygotic gene expression is
restored if the effector kinase of the DNA damage checkpoint
pathway, Chk2, is also mutated [19]. This indicates that a Chk2-
dependent DNA damage pathway can suppress zygotic transcrip-
tion.
In this study we investigated how the unstable regulatory
protein Geminin regulates the expression of zygotic genes at the
mid-blastula transition. Geminin is thought to maintain cells in an
undifferentiated state while they proliferate [20,21]. Geminin is a
bi-functional protein. It limits the extent of DNA replication to one
round per cell cycle by binding and inhibiting the essential
replication factor Cdt1 [22,23,24]. Geminin also inhibits tran-
scription in several different tissues by binding and inhibiting
various transcription factors and chromatin remodeling proteins
[25,26,27]. Because Geminin regulates both the cell cycle and
tissue-specific transcription, it has been suggested that the protein
somehow coordinates cell division with cell differentiation.
We previously showed that Xenopus embryos lacking Geminin
arrest in G2 phase just after the 13
th cell division, one cell cycle
after the MBT is reached [28]. The cell cycle arrest is caused by
activation of the Chk1-dependent DNA replication checkpoint.
Geminin-depleted embryos retain viability for several hours but
then disintegrate during gastrulation. Here we report that when
Geminin is depleted the expression of most zygotic genes at the
MBT is sharply reduced, and that the expression defect is a
consequence of abnormal DNA replication. We conclude that
Geminin is required to maintain genomic integrity during the
early cleavage divisions, and that DNA damage disrupts zygotic
transcription at the MBT, probably through activation of DNA
damage-induced checkpoint mechanisms. We could not demon-
strate that Geminin has a replication-independent effect on
transcription.
Results
Geminin is required for early embryonic gene expression
in Xenopus
To inhibit Geminin expression we injected two-cell Xenopus
embryos with 32 ng of anti-Geminin morpholino oligonucleotides
(a-Gem MOs), which cause a .95% reduction in the amount of
Geminin protein through at least the gastrula stage (Fig. 1A, [28]).
When the embryos reached the onset of gastrulation (Nieuwkoop
stage 10.5) we compared the levels of a broad array of early
transcripts in Geminin-depleted and control embryos by quanti-
tative real-time PCR (RT-PCR). Geminin-depleted embryos
showed a marked reduction in the expression of most early
transcripts (Fig. 1B), including patterning genes of the Spemann
organizer (Goosecoid (Gsc)), genes in the Wnt signaling pathway
(Xwnt8, Sizzled (Szl)), genes in the BMP signaling pathway
(Chordin (Chrd), Vent2), and genes expressed in the three germ
layers (Brachury (Xbra, mesoderm), epidermal keratin (Epiker,
epidermis), Zic3 (neural plate), and Sox17 (endoderm). The
transcript levels of two genes expressed before the MBT, Nodal-
related 5 (Xnr5) [29] and ID2 [30], were not significantly affected.
Only two genes, Msx1b and Xenopus-posterior (Xpo), showed
preserved induction in Geminin-depleted embryos. These results
show that Geminin depletion causes widespread defects in zygotic
transcription but has less of an effect on genes expressed before the
MBT. The decrease in gene expression is not specific to any
particular signaling pathway, organ system, or germ layer.
We next used in situ hybridization to examine how Geminin
depletion affects the pattern of expression of Gsc and Xbra, two
genes with a distinctive and well-known embryonic localization.
Gsc is normally expressed in the Spemann organizer on the dorsal
side of the embryo close to the blastopore lip (Fig. 1C, [31]). When
Geminin is depleted, Gsc expression is still detected on the dorsal
side near the blastopore lip but expression is not as tightly localized
(Fig. 1D). Xbra is normally expressed in a circumferential band of
cells that give rise to the embryonic mesoderm (Fig. 1F, [32]).
When Geminin is depleted, Xbra expression is barely detectable
but the small amount of residual expression shows the normal
circumferential staining pattern (Fig. 1G). Neither Gsc nor Xbra
expression could be detected in embryos injected with the RNA
polymerase II inhibitor a-amanitin (Figs. 1E and 1H). These
results indicate that Geminin depletion affects the level of gene
expression but not the pattern or the timing.
When only one cell of the two-cell embryo was injected with
antisense oligo, Xbra expression was lost only on the injected side
(Fig. 1I). This indicates that the Geminin-depleted embryos survive
until the stage in development when zygotic gene expression
begins, and that the effects of Geminin depletion are cell-
autonomous (see below). TUNEL staining indicated that the
Geminin-depleted cells had not undergone apoptosis (Fig. S1, A–
C). The Geminin-depleted cells are noticeably larger than
uninjected cells at this stage of development, indicating that they
have undergone a cell cycle arrest (Fig. 1I, compare cell size on
either side of the dotted line).
Xbra expression is restored by injecting Geminin-depleted
embryos with synthetic Geminin RNA that has been mutated so
that it does not interact with the anti-Geminin MOs (Fig. 2A,
[28]). This indicates that the expression defect results specifically
from the loss of Geminin and not from an off-target effect of the
oligonucleotides. Xbra expression was not completely restored to
the normal level, probably because Geminin RNA does not diffuse
as freely throughout the embryo as the antisense oligonucleotides.
To confirm this, we repeated the experiment and co-injected b-
galactosidase RNA as a lineage tracer to demarcate the injected
Geminin Is Required for Zygotic Transcription
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injection site where Geminin was expressed (Figs. 2B–D).
Geminin’s Effects are Cell Autonomous
Gsc and Xbra are induced by extracellular signals that emanate
from the Nieuwkoop signaling center on the dorsal side of the
embryo [33]. The loss of Gsc and Xbra expression in Geminin-
deficient embryos could reflect either a failure of the Nieuwkoop
center to generate these signals or a failure of uncommitted cells to
respond to them. Our observation that residual Gsc and Xbra are
still expressed in a spatially and developmentally specific pattern
suggests that the signals inducing Gsc and Xbra expression are
intact. Furthermore, when only one cell of a two-cell embryo was
injected, we occasionally observed small islands of Xbra-express-
Figure 1. Geminin is Required for Zygotic Gene Expression. (A) Immunoblot showing complete depletion of Geminin by anti-Geminin
morpholino oligonucleotides (a-Gem MOs). XRBs, cross-reacting bands serving as a loading control. Geminin runs as a tightly spaced doublet at
,35 kD. (B) Real-time PCR (RT-PCR) data showing decreased expression of most genes in Geminin-depleted embryos at stage 10.5. The expression
level if each RNA was normalized to the expression in control embryos (Co). n, number of independent experiments; asterisk indicates P,0.001
(paired t-test); NS, not significant. (C–H) In situ hybridization for Gsc (C–E) and Xbra (F–H) at stage 10.5 showing that depleting Geminin preserves the
pattern of expression for both genes. Both cells of two-cell Xenopus embryos were left uninjected (Co) or injected with either anti-Gem MOs or a-
amanitin. (I) Xbra expression is affected only in Geminin-depleted cells. One cell of a two-cell embryo was injected with anti-Geminin MOs
(arrowhead) and in situ hybridization for Xbra was performed when the embryo reached stage 10.5. Note the markedly larger cells on the injected
side (dotted line), indicating that the cells have stopped dividing.
doi:10.1371/journal.pone.0038009.g001
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expressing cells (not shown). This pattern is more consistent with a
cell-autonomous defect in responding to extracellular induction
signals.
To confirm this, we dissected undifferentiated animal caps from
Geminin-depleted or control embryos and exposed them to
recombinant human Activin A, a mesoderm-inducing soluble
ligand protein that reproduces the signals coming from the
Nieuwkoop center. In control animal caps, activin treatment
induces Gsc expression about 40-fold and Xbra expression about
100-fold (Fig. 3, compare gray and black bars). In Geminin-
depleted caps, activin-induced Gsc expression is reduced 5-fold
and Xbra expression is reduced 50-fold (Fig. 3, compare black and
red bars), mirroring the results seen in intact embryos. Similar
results were obtained with Xwnt8 and Zic3 expression. Further-
more, Xnr5 expression was not affected by Geminin depletion, as
was observed in intact embryos. These results indicate that
Geminin’s effects on zygotic gene expression are cell-autonomous.
Gene Expression Defects are due to Over-activity of Cdt1
It has been reported that Geminin represses gene expression
through interactions with homeobox (Hox) proteins, sine-oculis
(Six) transcription factors, the Polycomb protein Scmh1, the BMP
signaling pathway, and the chromatin remodeling protein Brg1
[25,26,27,34,35]. We next tested whether reduced zygotic gene
expression in Geminin depleted embryos was linked to an effect on
DNA replication or the result of an independent action of
Geminin on transcription. Geminin regulates DNA replication by
binding and inhibiting the essential replication factor Cdt1. We
previously generated two Geminin mutants (Geminin
SAPD and
Geminin
D100–117) that do not bind Cdt1 and do not inhibit DNA
replication when added to extracts of Xenopus eggs [36]. To see if
either mutant could rescue Xbra expression, we injected two-cell
embryos with a-Gem MOs and 30 pg of RNA encoding either
WT Geminin or one of the Cdt1 binding mutants, along with ß-
galactosidase RNA as a lineage tracer. At stage 10.5, neither non-
binding mutant restored Xbra expression in any of the embryos,
while Geminin
WT restored expression in almost all (Fig. 4A–C, D).
We also tested two other Geminin missense mutants (Geminin
KK-
FEV and Geminin
RTGG) that map to the same region as
Geminin
SAPD and Geminin
D100–117 yet bind Cdt1 normally [36].
These mutants were also able to rescue Xba expression. The
ability of each mutant to restore Xbra expression was directly
Figure 2. Geminin Expression Restores Zygotic Gene Expression. (A) Two-cell embryos were left uninjected (Control), injected on both sides
with anti-Geminin MOs, or injected with anti-Geminin MOs followed by RNA encoding a MO-resistant version of Geminin
WT. At stage 10.5 the amount
of Xbra RNA was determined by RT-PCR. The average of two measurements is shown. (B–D) Same as (A), except only one cell of a 2-cell embryo was
injected (arrowheads) and LacZ RNA was co-injected with Geminin
WT RNA to serve as a lineage tracer. At stage 10.5 Xbra RNA was visualized by in situ
hybridization (purple) and ß-galactosidase activity was visualized by staining with Xgal (blue). The dotted lines indicate the border between the
uninjected half and the injected half.
doi:10.1371/journal.pone.0038009.g002
Figure 3. Geminin’s Effects on Gene Expression are Cell-
Autonomous. Animal caps were dissected from control (black bars)
or Geminin-depleted (red bars) embryos at the early blastula stage
(Nieuwkoop stage 8) and incubated in 20 ng/ml Human Activin A.
When companion embryos reached stage 10.5, RNA was isolated from
the caps and message levels were measured by RT PCR as described
above. Gray bars, message level in control caps not treated with activin;
n, number of measurements; asterisk indicates P,0.002 (paired t-test);
NS, not significant.
doi:10.1371/journal.pone.0038009.g003
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arrest caused by depleting Geminin (Fig. 4D, see below).
Immunoblotting confirmed that each mutant was expressed at
the same level (Fig. 4E). These results indicate that Geminin must
be able to bind Cdt1 in order to rescue zygotic gene expression.
We next tested whether over-expressing Cdt1 by itself
reproduces the defects in transcription seen with Geminin
Figure 4. Geminin Mutants that don’t bind Cdt1 fail to restore Xbra Expression. (A–C) One cell of a two-cell embryo was injected with anti-
Gem MOs and RNA encoding a MO-resistant version of either Geminin
WT or various Geminin mutants along with LacZ RNA as a lineage tracer. At
stage 10.5 Xbra RNA was visualized by in situ hybridization (purple) and ß-galactosidase activity was visualized by staining with Xgal (blue). The white
dotted line indicates the border between the injected and the uninjected side. (D) Graph showing percentage of embryos showing restoration of
Xbra expression (black bars) and the percentage of embryos showing suppression of the cell cycle arrest (gray bars) in the injected area. The average
and standard deviation of three measurements is shown. (E) Immunoblot showing equivalent expression of all Geminin mutants. Note that Geminin
was not completely depleted (lane 2) because only one side of the embryo was injected with MOs. XRBs, cross-reacting bands serving as a loading
control; arrowheads, Geminin mutants; asterisks, Geminin degradation products.
doi:10.1371/journal.pone.0038009.g004
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mutant of Cdt1 (Cdt1
NGB) that retains its full activity as a
replication factor, and a different non-binding mutant that is
catalytically inactive (Myc-Cdt1
N331) [37]. We injected one cell of
two-cell Xenopus embryos with different concentrations of RNA
encoding Cdt1
WT, Cdt1
NGB, or Myc-Cdt1
N331 along with ß-
galactosidase RNA as a lineage tracer. Immunoblotting confirmed
that each Cdt1 mutant was expressed at the same level (Fig. 5A).
Expressing either Cdt1
WT or Cdt1
NGB inhibited Xbra expression,
while expressing the catalytically inactive Myc-Cdt1
N331 had no
effect (Fig. 5B–C). The non-Geminin binding mutant was more
potent at suppressing Xbra expression than the wild-type protein
(Fig. 5D), as was a stabilized form of Cdt1 (Cdt1
N150) that does not
get proteolyzed during S phase (Fig. 5E, [37]). Over-expressing
Cdt1
C479, a C-terminal deletion mutant that binds Geminin but is
inactive as a replication factor [37] does not affect Xbra expression
(Fig. 5E). TUNEL assays showed that cells expressing the most
potent mutant, Cdt1NGB, had not undergone apoptosis (Fig.
S1D). We conclude from these experiments that the reduced gene
expression in Geminin depleted embryos is a consequence of over-
activity of Cdt1. Cdt1 is required for the assembly of pre-
replication complexes during S phase but has no other known
function [38]. The results of Cdt1 over-expression indicate that the
effect of Geminin on Xbra transcription is caused by over-
replication of the DNA.
Hydroxyurea Reproduces the Transcription Defects
caused by Geminin Deletion
We next tested whether chemical DNA damaging agents have a
similar effect on transcription as Geminin depletion. Hydroxyurea
(HU) blocks DNA replication by inhibiting the enzyme ribonu-
cleotide reductase and depleting the pool of deoxyribonucleotide
triphosphates. Treating Xenopus embryos with HU activates both
the DNA replication checkpoint and DNA damage checkpoint
pathways, and the cells stop dividing immediately after the 12
th
cell division [28,39]. HU-treated Xenopus embryos show the same
pattern of transcriptional abnormalities as Geminin-depleted
embryos: the expression of most zygotic genes is reduced while
the expression of Xpo, ID2, and Msx1b is preserved (Fig. 5F).
TUNEL staining showed that some of the cells in HU-treated
embryos had undergone apoptosis (Fig. S1E), but apoptosis did not
seem extensive enough to fully account for the changes in gene
expression (compare Fig. S1 A and E). This indicates that a DNA
damaging agent has the same effect on transcription as Geminin
depletion.
Suppressing the Cell Cycle Arrest does not Restore Xbra
Expression
We previously showed that Geminin depletion arrests blastula
cells in the G2 phase of the cell cycle because over-replication of
the DNA activates the Chk1-dependent DNA replication check-
point pathway (Fig. 6A, [28,37,40]). Activation of the checkpoint is
manifest by the appearance of Chk1 phosphorylated on serine-345
(see Fig. 7, lanes 1–2). Chk1 arrests cells in G2 phase by
phosphorylating Cdc25 on serine-287, causing it to bind 14-3-3
proteins and be sequestered in the cytoplasm where it cannot
activate the mitotic kinase Cdc2 (Fig. 6A, [41,42]). Because of the
G2 arrest, Geminin-depleted embryos have visibly larger cells than
control embryos at the late blastula stage (see Figs. 1I, 2C, and
6D). They also exhibit two molecular signatures of G2 phase:
excessive accumulation of mitotic cyclins and complete phosphor-
ylation of Cdc2 on tyrosine-15 (Fig. 6B, compare lanes 1–2 and 4–
5; [28]). We previously showed that the G2 arrest could be
bypassed by over-expressing constitutively active forms of Cdc25
or Cdc2 (Cdc25
S287A or Cdc2
AF, respectively) or by over-
expressing a dominant negative mutant of Chk1 (Chk1
DA) [28].
To test whether the gene expression defects in Geminin-
depleted embryos are caused by the cell cycle arrest, we suppressed
the checkpoint pathway by injecting 2-cell embryos with both a-
Gem MOs and RNA encoding either Cdc2
AF, Cdc25
WT,
Cdc25
S287A, or Chk1
DA. Over-expression of each protein
efficiently reversed the cell cycle arrest caused by Geminin
depletion, as indicated by the disappearance of large arrested
cells near the injection site (Fig. 6C) and a reduction in the
amounts of cyclin B1 and phosphorylated Cdc2 (Fig. 6B, compare
lanes 2–3 and 5–6; data not shown; and [28]). Although the
Geminin-deficient cells continued to divide past the point they
would normally arrest, there was virtually no restoration of Xbra
expression as judged by either RT-PCR or by in situ hybridization
(Figs. 6D–6G, 6N). We conclude that reduced expression of
zygotic genes in Geminin-depleted embryos is not a direct
consequence of a G2 cell cycle arrest. Moreover, we found that
injecting normal embryos with RNA encoding either Cdc25
S287A,
Cdc2
AF, or Chk1
DA by itself caused a drastic reduction in Xbra
expression even when the Geminin concentration was normal
(Figs. 6H–M). The reduction was evident both by RT-PCR and by
in situ hybridization (Fig. 6N). The in situ hybridization data show
a more striking decrease in Xbra expression because the injected
RNA does not diffuse freely throughout the embryo, as indicated
by the limited area of X-gal staining. Injection of Cdc2
WT RNA,
which does not suppress the checkpoint [28], had no effect (Figs. 6I
and 6N). Expression of Cdc2
AF also caused a significant decrease
in the expression of Gsc, Xwnt8, and Zic3 as measured by RT
PCR (Figure S2). TUNEL staining showed that expressing Cdc2
AF
or Cdc25
SA did not cause widespread cellular apoptosis (Fig. S1 F–
G). Expressing Chk1
DA did cause some apoptosis of cells in the
injected area (Fig. S1H). This ‘‘toxic’’ effect of expressing Chk1
DA
may be nonspecific because much more Chk1
DA RNA was
injected compared to Cdc2
AF or Cdc25
SA RNA (5000 pg vs.
150 pg). Considering all the results, we conclude that an intact
DNA replication checkpoint pathway is also required for zygotic
gene expression.
Geminin Deletion Generates Double Stranded Breaks
Previous work in Drosophila has demonstrated that DNA-
damaging agents or mutations in the Chk1 pathway generate
double-stranded breaks, and that these forestall zygotic gene
expression at the MZT through activation of the Chk2-dependent
DNA damage checkpoint pathway [19]. We thought this
mechanism might account for the gene expression defects in both
Geminin-depleted embryos and in embryos where the Chk1
pathway has been suppressed. To check directly for the presence
of DNA damage, we blotted embryo extracts with phosphospecific
antibodies raised against S
139-phosphorylated H2A.X, a modified
histone that accumulates at double-stranded breaks [43,44].
Geminin-depleted embryos exhibited robust phosphorylation of
H2A.X on S
139, indicating that Geminin deletion generates
double stranded breaks (Fig. 7, lanes 2, 11, and 14). We also
detected H2A.X phosphorylation in embryos injected with RNA
encoding Cdt1
WT or Cdt1
NGB (lanes 3–4); embryos in which the
DNA replication checkpoint was bypassed by injecting RNA
encoding Cdc2
AF, Cdc25
WT, Cdc25
S287A, or Chk1
DA (lanes 8, 9,
12, and 15); and embryos treated with hydroxyurea (lane 7). Thus,
every treatment that inhibited zygotic gene expression also
induced double stranded breaks.
Chk2 activation requires phosphorylation of the activation loop,
which can be detected by either an electrophoretic mobility shift
Geminin Is Required for Zygotic Transcription
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T
383 (Fig. 8B, [45,46,47]). To see if the Chk2-dependent pathway
had been activated, we blotted embryo extracts with antibodies to
either total Chk2 or T
383-phosphorylated Chk2. We detected
robust phosphorylation of Chk2 in hydroxyurea-treated embryos,
Cdc2
AF-injected embryos, and Cdc25
S287A-injected embryos
(Fig. 8A–B). In contrast, there was little if any Chk2 phosphor-
ylation in Geminin-depleted embryos.
We also tested whether inhibition of the Chk2 pathway would
restore Xbra expression to Geminin-depleted embryos by injecting
embryos with RNA encoding a dominant negative form of Chk2
kinase, Chk2
DN [48]. Chk2
DN did not restore Xbra expression in
Geminin-depleted embryos, whether measured by in situ hybrid-
Figure 5. DNA Damage Reproduces the Effects of Depleting Geminin. Two-cell Xenopus embryos were injected on one side with RNA
encoding Cdt1
WT or different Cdt1 mutants along with LacZ RNA as a lineage tracer then analyzed at stage 10.5. (A) Immunoblot showing equivalent
expression of Cdt1 WT, Cdt1NGB, and myc-Cdt1N331. (B, C) Typical appearance of embryos injected with myc-Cdt1
N331 or Cdt1
NGB. (D) Percentage of
embryos with reduced Xbra expression in the injected area as a function of the amount of Cdt1
WT or Cdt1
NGB RNA injected. (E) Percentage of
embryos showing reduced Xbra expression after injection of 300 pg of RNA encoding different Cdt1 mutants. The average and standard deviation of
three measurements is shown. An asterisk indicates P,0.01; a double asterisk indicates P,0.001 compared to injection of Cdt1
WT. (F) Two-cell
embryos were injected on both sides with anti-Geminin MOs (gray) or incubated in 20 mM hydroxyurea (black). At stage 10.5 RNA levels were
measured by RT-PCR. The average value of three independent experiments is graphed. NS, not significant.
doi:10.1371/journal.pone.0038009.g005
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DN also failed to
restore Xbra expression to embryos that had been injected with
RNA encoding Cdc2
AF, Cdc25
S287A, or Chk1
DN (Fig. 8E).
Immunoblots showed that Chk2
DN protein was expressed at
about the same level as endogenous Chk2 (not shown), which may
have been insufficient to completely inhibit the kinase. Injecting
embryos with anti-Chk2 morpholino oligonucleotides did not
affect the Chk2 protein level, and injecting embryos with anti-
Figure 6. Suppressing the Cell Cycle Arrest does not Restore Xbra Expression. (A) The signaling pathway that controls entry into mitosis.
See text for details. (B) Arrested Geminin-deficient cells exhibit increased phosphorylation of Cdc2 on Y
15 and increased levels of B-type cyclins; and
these changes are reversed by over-expressing either Cdc2
AFor Cdc25
S287A. Two-cell embryos were left uninjected (CO), injected on both sides with
anti-Gem MOs (a-Gem MOs), or injected with anti-Gem MOs followed by RNA encoding Cdc2
AF or Cdc25
S287A. At stage 10.5, phosphorylated Cdc2
and cyclin B1 levels were determined by immunoblotting. Load, cross-reacting band serving as a loading control. (C) The cell cycle arrest is reversed
by over-expressing Cdc25
WT, Cdc25
S287A, Cdc2
AF, or Chk1
DA. One cell of a two-cell embryo was injected with anti-Geminin MOs and RNA encoding
the indicated proteins. The plot shows the percentage of embryos in which cell division was restored in the injected area at stage 10.5. (D–M) One cell
of a two-cell embryo was injected with anti-Gem MOs and/or RNA encoding the indicated proteins. LacZ RNA was co-injected as a lineage tracer. At
stage 10.5 Xbra RNA was visualized by in situ hybridization (purple) and beta galactosidase activity was visualized by staining with Xgal (blue). (N)
Both sides of a two-cell embryo were injected with anti-Geminin MOs and/or RNA encoding the indicated proteins. At stage 10.5, RNA was extracted
and the amount of Xbra mRNA was measured by RT-PCR (gray bars). In a parallel experiment, one cell of a 2-cell embryo was injected in the same way
along with LacZ as a lineage tracer. At stage 10.5 Xbra was visualized by in situ hybridization and the percentage of embryos showing normal Xbra
expression was determined (black bars).
doi:10.1371/journal.pone.0038009.g006
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Incubating Geminin-depleted embryos in medium containing the
Chk2 inhibitor 2-4-4-chlorophenoxyphenyl benzimidazole 5-
carboxamide did not restore Xbra expression (not shown). In
summary, by using a variety of methods, we could not
demonstrate that inhibiting Chk2 activity restores gene expression
in Geminin-depleted embryos. Embryos expressing Chk2
DN had
normal Xbra expression (Fig. 8C and E), did not exhibit increased
cellular apoptosis (Fig. S1I) and developed normally to the tadpole
stage (not shown).
It has recently been reported that Geminin knockdown
enhances the expression of some embryonic genes as much as
10-fold [35]. We tested the expression of four of the most highly
induced genes: Epiker, Msx1b, ID2, and Xpo. With Geminin
depletion, expression of these genes either did not change (Msx1b,
ID2) or went down (Epiker) (Fig. 1B). Xpo RNA was induced
about ,2-fold but this result was extremely variable and not
statistically significant. The other workers injected less anti-
Geminin MO than we did (5 ng vs. 32 ng), so we tested whether
this difference in technique was responsible for the conflicting
results. At the lower dose of a-Gem MO, Geminin was only
partially depleted (,75%); embryos rarely exhibited a cell cycle
arrest (24614% of embryos); and that levels of S
345-phosphory-
lated Chk1 and S
193-phosphorylated H2A.X were lower com-
pared to embryos where Geminin was completely depleted (Fig.
S3, right panel). At the lower dose, the expression of most
measured genes was intermediate between the level in untreated
embryos and the level in fully depleted embryos (Fig. S3, left
panel), This result argues against the possibility that there are
threshold effects of depleting Geminin on gene expression. We
suspect that the differences between our results and those
previously published are mostly due to variability of gene
expression in outbred frog populations and slight differences in
the time when the embryos were collected.
Discussion
In this paper we show that Geminin-deficient Xenopus embryos
have a widespread defect in zygotic gene expression at the mid-
blastula transition. The transcription of most genes is sharply
reduced, while the expression of genes activated before the MBT,
e.g. Xnr5 and ID2, is maintained. Zygotic induction was preserved
for only two genes, Msx1b and Xpo. Geminin depletion
apparently does not interfere with the timing mechanisms that
cause zygotic transcription to initiate after the 12
th cell division,
since a small residual level of Gsc and Xbra transcription occurs in
the right place and at the right time. This is consistent with
prevailing models, since Geminin loss does not affect the nuclear
to cytoplasmic ratio, nor would it be expected to affect intrinsic
maternal clock mechanisms that initiate at fertilization. Rather,
Geminin loss affects the degree to which zygotic genes are
expressed. Defects in zygotic gene expression may contribute to
the early embryonic mortality of Geminin-depleted Xenopus and
mouse embryos [28,49,50]. Geminin-deficient Drosophila embry-
os survive to larval stages, perhaps because of a maternal supply of
Geminin RNA and protein [51].
The most parsimonious explanation of our results is that
Geminin depletion inhibits zygotic gene expression because it
leads to DNA damage. We previously showed that Geminin
deletion causes a partial second round of DNA replication within a
single S phase, and others have shown that Geminin knockdown in
cultured cells generates both double stranded breaks and single
stranded regions [52,53,54,55]. Here we find that we can
reproduce the effects of Geminin depletion on transcription by
over-expressing Cdt1, a protein negatively regulated by Geminin
and whose only known function is in DNA replication. This
strongly suggests that over-replication of the DNA is responsible
for the suppression of transcription. We can also suppress
transcription by treating embryos with hydroxyurea or by
bypassing the Chk1-dependent DNA replication checkpoint.
DNA damage is a common feature of all the treatments that
suppress transcription, as evidenced by the appearance of H2A.X
phosphorylated on S
139, a marker for double stranded breaks
[43,44]. It seems unlikely that these abnormal DNA structures by
themselves abort nascent zygotic transcripts because in the
absence of Geminin the total amount of re-replicated DNA is
less than a few percent [28,37].
It seems more likely that DNA damage inhibits transcription
through activation of a checkpoint mechanism. It has previously
been shown in Drosophila that activation of the Chk2-dependent
DNA damage checkpoint pathway can block zygotic gene
expression [19]. The Chk2 pathway can be activated either
directly by injecting DNA damaging chemicals or indirectly by
mutating the Chk1 protein, which causes double stranded breaks
when cells enter mitosis before DNA synthesis is finished [18]. The
Chk2 pathway also seems to inhibit zygotic transcription in
Xenopus, since either incubating embryos in hydroxyurea or
bypassing the Chk1 pathway also induces DNA damage, activates
Figure 7. Treatments that Suppress Zygotic Gene Expression Cause DNA Damage. Two-cell Xenopus embryos were injected on both sides
with anti-Geminin MOs and/or RNA encoding the indicated proteins. The levels of S
345-phosphorylated Chk1, S
139-phosphoryated H2A.X, and
Geminin were determined by immunoblotting.
doi:10.1371/journal.pone.0038009.g007
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model would be to show that inhibition of Chk2 signaling restores
zygotic gene expression. In Drosophila this was accomplished by
using Chk2(2/2) mutant strain, but unfortunately such a strain is
not available in Xenopus. Because we could not reliably inhibit
Chk2 in Xenopus embryos, the conclusion that Chk2 activation
inhibits zygotic gene expression must remain somewhat tentative.
The DNA damage response pathways may be more complex in
vertebrates than they are in Drosophila, and it may not be possible
to overcome them simply by inhibiting Chk2. Depleting Geminin
does not consistently induce Chk2 phosphorylation, suggesting
that a different checkpoint pathway could be involved. In
Figure 8. Suppressing the DNA Damage Checkpoint does not restore Zygotic Gene Expression. (A, B) Hydroxyurea treatment or
suppression of the DNA replication checkpoint pathway causes activation of the DNA damage checkpoint kinase Chk2. Two-cell Xenopus embryos
were left uninjected, treated with hydroxyurea, or injected on both sides with anti-Geminin MOs or RNA encoding the indicated proteins. At stage
10.5, immunoblots were performed for total Chk2, Geminin, and T
383-phosphorylated Chk2. (C, D). One cell of a 2-cell embryo was injected with RNA
encoding Chk2
DN with or without anti-Geminin MOs, along with ß–galactosidase RNA as a lineage trader. At stage 10.5, in situ hybridization was
performed to visualize Xbra expression (purple) and X–gal staining was performed to visualize ß–galactosidase expression (blue). (E) 2-cell embryos
were injected on both sides with anti-Geminin MOs and/or the indicated RNAs. At stage 10.5, Xbra RNA expression as measured by in situ
hybridization (gray bars) and RT-PCR (black bars). ND, not determined.
doi:10.1371/journal.pone.0038009.g008
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involving p38-MAPK arrests the cell cycle and promotes cellular
survival [56]. Although MAPK signaling pathways are functional
during early Xenopus development [57], we could not consistently
demonstrate activation of p38-MAPK in Geminin-depleted
embryos, nor could we restore Xbra expression by inhibiting this
pathway (not shown). An alternate explanation is that ongoing
DNA replication changes the structure of the chromatin template
in some way that is not conducive to efficient transcription.
We could not demonstrate that Geminin has an independent
effect on zygotic transcription that is separate from its effect on
DNA replication. It has been previously reported that Geminin
represses gene expression at the MBT through an interaction with
the Polycomb complex PRC2 [35]. This conclusion was based on
the finding that over-expressing the deletion mutant Geminin
Dcoil
repressed the expression of several genes (including Xbra) and that
the repression was relieved by injecting antisense MOs to the
PRC2 subunits Suz12 or Ezh2. Geminin
Dcoil does not affect DNA
replication [22,34], so this mechanism appears to be separate from
the one discussed here. We did not consistently observe over-
expression or premature expression of any gene when Geminin
was depleted (Fig. 1B and not shown). Furthermore, in our hands
inhibiting PRC2 function by injecting an antisense MO to the
Suz12 subunit (using the same conditions as in [35]) had no effect
on development to the tadpole stage (Nieuwkoop stage 44), nor did
it affect Xbra expression in control or Geminin-depleted embryos
(not shown). Geminin has also been previously shown to inhibit
transcription in several different tissues by interacting with various
transcription factors and chromatin remodeling proteins
[25,26,27,34]. These include Homeobox (Hox) transcription factors;
Brg1, the catalytic subunit of a SWI/SNF chromatin-remodeling
ATPase; and the Polycomb group protein Scmh1, a sub-stoichio-
metric subunit of the PRC1 chromatin remodeling complex that
maintains previously established transcriptional repression [26].
These regulatory interactions occur at later stages in development
that Geminin-depleted embryos never reach. We found that over-
expression of Scmh1 had no discernible effect on early Xenopus
development or on Xbra expression in control or Geminin-
depleted embryos (not shown). The significance of the Geminin-
Scmh1 interaction remains a subject for further investigation.
The absolute requirement for Geminin during early develop-
ment stands in stark contrast to its apparent dispensability at later
stages. Deleting Geminin from mouse T lymphocytes, leukocytes,
or neural stem cells has little effect on the production or function of
these cells, even though it may cause subtle cell cycle defects
[58,59,60,61]. The exquisite sensitivity of early embryonic cells to
Geminin depletion may reflect some peculiar aspect of their cell
cycle. Depleting Geminin from hematopoietic stem cells has a
striking effect on the types of cells that they give rise to: it abolishes
the production of red blood cells but greatly enhances the
production of megakaryocytes [60]. It is not yet known whether
this is a consequence of a greater sensitivity of red cell precursors
to replication damage or whether Geminin has a replication-
independent effect on the differentiation of Megakaryocyte-
Erythrocyte Progenitors.
Materials and Methods
Ethics Statement
All animal work was performed according to the protocol
approved by the Northwestern University Animal Care and Use
Committee (Protocol # 2009-0911).
Xenopus
Adult male and female frogs were purchased from Nasco.
Induction of ovulation and in vitro fertilization were carried out
using standard techniques (Sive et al., 2000). Eggs from albino
mothers were used for the TUNEL experiments.
RNA Synthesis
Plasmid constructs encoding Geminin
WT, Geminin mutants,
Cdt1
WT, Cdt1
NGB, Cdt1
C479, Cdc25, Cdc25
SA, Cdc2
WT, and
Cdc2
AF were previously described [22,28,36,37]. A plasmid
encoding Chk1
DA was kindly provided by Noriyuki Sagata [62].
Plasmids encoding Chk2
WT and Chk2
DN were kindly provided by
Jill Sible [48]. Chk2
DN has previously been shown to have
dominant-negative effects when over-expressed in Xenopus
embryos [48,63]. For in vitro RNA synthesis, plasmid constructs
were linearized with Not I and transcribed with SP6 or T7
polymerase in the presence of ribonucleotide triphosphates and
diguanosine triphosphate cap (m
7GpppG, GE Healthcare) ac-
cording to protocols provided by the supplier of the enzyme
(Promega). RNAs were resuspended and diluted in water before
injection.
Microinjection
Embryos were injected at the two-cell stage with a volume of
10 nl per cell. To deplete Geminin, embryos were injected with
16 ng per cell of an equal mixture of anti-Geminin H and anti-
Geminin L morpholino oligos (Gene Tools LLC) as previously
described [28]. For some experiments, 2.5 ng of anti-Geminin H
oligo was injected per cell as described [35]. To express proteins,
embryos were injected with 30–8000 pg of synthetic RNA per cell.
The amounts injected were as follows: Geminin and Geminin
mutants 30 pg/cell; Cdt1 and Cdt1 mutants 15–500 pg/cell;
Cdc2
AF and Cdc25
S287A 150 pg/cell; Chk1
DA 5000 pg/cell; and
Chk2
DN 5000–7500 pg/cell. Morpholino oligos and RNAs were
injected separately.
Real Time PCR
Five embryos from the same clutch of eggs that had been
identically treated were pooled for each measurement. Embryos
were homogenized in RNA extraction buffer (50 mM Tris-HCl
pH 7.5, 50 mM NaCl, 5 mM EDTA, 0.5% SDS) and treated with
0.4 mg/ml protease K for 30 min at 45uC followed by phenol/
chloroform extraction. Nucleic acids were ethanol precipitated
and resuspended in Transcription Buffer (Promega) containing
0.8 mM fresh DTT and 6 U RNAsin (Promega). DNA was
digested by adding 1 U RQ1 DNAse (Promega) and incubating at
37uC for 30 minutes. The samples were re-extracted with phenol/
chloroform, re-precipitated with ethanol, and resuspended in
water. cDNA synthesis was carried out using a standard kit
(Ambion) and RT-PCR was performed using an Applied
Biosystems 7500 Fast Real Time PCR System. Primers and
fluorescently labeled probes for RT-PCR were designed using
Primer Design software (Applied Biosystems). All RNA levels were
normalized to the amount of 18S ribosomal RNA in each sample
and expressed as a percentage of the RNA level in control embryos
from the same mother. Animal caps were dissected at stage 8 [64]
and cultured in MBSH (110 mM NaCl, 2 mM KCl, 1 mM
MgSO4, 2 mM NaHCO3, 0.5 mM sodium phosphate, 14 mM
Tris pH 7.6) containing 0.1% BSA, with or without 20 ng/ml
Human Activin A (Sigma). RNA was isolated when companion
embryos reached the early gastrula stage (Nieuwkoop stage 10.5).
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In all cases where results were analyzed statistically, at least
three independent experiments were performed. An independent
experiment is one where the embryos came from a separate
mother. The expression of each gene was calculated as a
percentage of the expression level in control embryos from the
same mother. P values were calculated using Student’s paired t-
test; paired samples came from the same mother.
In situ hybridization
In situ hybridization with digoxigenin-labeled probes and X-gal
(5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) staining were
performed using standard techniques [65], except that treatment
with RNases A and T1 was omitted. Plasmids encoding antisense
probes for Xbra and Gsc were kindly supplied by Sergei Sokol
[66,67]. DIG-RNA labeling mix, alkaline phosphatase-conjugated
anti-Digoxigenin Fab fragments, and BM-purple AP precipitating
substrate were purchased from Roche. Stained embryos were
scored blindly to avoid biasing the results.
TUNEL Staining
TUNEL staining was performed using published techniques
[68,69], except that immediately after fixation and rehydration the
embryos were rinsed in antigen retrieval buffer (10 mM sodium
citrate pH 6.0), steam heated to 100uC for 30 minutes in a double
boiler, and slowly cooled. As a positive control, embryos were
treated with DNAse I (1 U/ml in 50 mM Tris-HCl pH 7.5, 1 mg/
ml BSA) for 30 minutes at room temperature in order to induce
double stranded breaks. As a negative control, the terminal
deoxynucleotidyl transferase (TdT) enzyme (Invitrogen #10533-
065) and the digoxigenin-dUTP (Roche #11 093 088 910) were
left out of the reaction.
Antibodies
Antibodies raised against Xenopus Geminin and Cdt1 were
described previously [22,37]. Phosphospecific antibodies against
pS
139 H2A.X and pS
345 Chk1 were purchased from Cell
Signaling. Antibodies against Xenopus Chk2 were kindly supplied
by Akiko Kumagai and William Dunphy [45], and antibodies
against phospho-T
383 Chk2 were purchased from Abcam.
Supporting Information
Figure S1 Neither Geminin Depletion nor Bypass of the
DNA Replication Checkpoint causes Increased Apopto-
sis. Two-cell embryos were left uninjected (A, B), treated with
hydroxyurea (E), or injected on one side with anti-Geminin MOs
or RNA encoding with Cdt1
NGB, Cdc2
AF, Cdc25
SA, Chk1
DA,o r
Chk2
DN (C–D, F–I). RNA encoding b-galactosidase was co-
injected as a lineage tracer. When the embryos reached stage 10.5
they were fixed and stained for b-galactosidase activity using X-gal
(blue) and for apoptotic cells using the TUNEL reaction (purple).
(A) Positive control (embryos pre-treated with DNase I); (B)
Negative control (TdT and labeled nucleotide omitted from the
reaction). Some embryos showed a faintly positive TUNEL
reaction even on the uninjected side (F, I).
(TIF)
Figure S2 Bypass of the DNA Replication Checkpoint
causes a General Loss of Zygotic Transcription. Both cells
of a 2-cell embryo were injected with RNA encoding Cdc2
AF in
order to bypass the DNA Replication Checkpoint. When the
embryos reached stage 10.5, the expression of Xnr5, Gsc, Xbra,
Xwnt8, and Zic3 was measured by RT PCR. Asterisk indicates
P,0.05; double asterisk indicates P,0.01.
(TIF)
Figure S3 Partial Depletion of Geminin causes a
Phenotype Similar to that of Complete Depletion. Two-
cell embryos were injected on both sides with either 2.5 ng or
16 ng of anti-Geminin MOs/side. At stage 10.5, protein levels
were determined by immunoblotting (left panel) and RNA levels
were measured by RT PCR (right panel).
(TIF)
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